Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immune response to chemically modified proteome.
Tolerogenic dendritic cells produced by Lentiviral-mediated CD40- and IL-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing Th17 cells.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Astrogliosis During Acute and Chronic Cuprizone Demyelination and Implications for Remyelination.
A new model of cuprizone-mediated demyelination/remyelination.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis.
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
The story of neuromyelitis optica continues to be written.
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
Age-associated changes in rat immune system: Lessons learned from experimental autoimmune encephalomyelitis.
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.
What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Targeting cells in motion: migrating toward improved therapies.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Pages
« first
‹ previous
…
395
396
397
398
399
400
401
402
403
…
next ›
last »